ArticleBMC medical imaging2025
Key refinements to a large animal model for measurement of real-time lymphatic transport.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe inability to directly measure real-time lymphatic transport hinders our understanding of lymphatic disorders and effective monitoring of therapeutic interventions. Here, we report three refinements to the use of novel near-infrared fluorophores in a large animal model for assessment of lymphatic function using optical fluorescence with the ultimate goal of direct clinical translation.
methodsA lymphadenectomy and lymphovenous bypass was performed in the left groin. Two different near-infrared (NIR) fluorophores composed of the identically same scaffold were injected into the respective hind limbs of female swine. Transit from injection sites into the lymphatic system and systemic circulation was assessed over three hours of NIR imaging immediately following injections. Albumin-conjugated fluorophores with 700 nm and 800 nm emission, respectively, were delivered with manual intradermal injection. Blood and urine samples were collected at standard time points. Continuous NIR imaging of the lymphovenous bypass and the superficial epigastric vein and its adjacent skin was also performed at standard time points. Blood and urine samples were collected to analyze systemic concentrations and renal excretion of both fluorophores, respectively. NIR imaging was performed to analyze real-time lymphatic transport of the fluorophores through the lymphovenous bypass and in the central circulation.
resultsFluorophore pharmacokinetics with albumin conjugation and manual intradermal injections produced inconsistent results. Three modifications to the study protocol were designed. Fluorophores were modified from albumin conjugation to polyethylene glycol (PEG) conjugation. Fluorophores were delivered with VAX-ID ® devices instead of manual intradermal injections. Additionally, a novel correction factor was developed to account for differences in NIR fluorescence between the fluorophores.
conclusionThe refinement of a large animal model to assess real-time lymphatic function represents a crucial step toward clinical translation. The optimized fluorophore composition and delivery mechanism captures dynamic changes in lymphatic function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.